Effects of Oral and Intravenous Administration of Buspirone on Food–Cocaine Choice in Socially Housed Male Cynomolgus Monkeys
暂无分享,去创建一个
[1] G. Curzon. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding. , 1991, Advances in experimental medicine and biology.
[2] Gregory S. Brigham,et al. Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. , 2014, The Journal of clinical psychiatry.
[3] D. Mash,et al. Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities , 1996, The Journal of Neuroscience.
[4] F. Gawin. Neuroleptic reduction of cocaine-induced paranoia but not euphoria? , 2004, Psychopharmacology.
[5] M. Nader,et al. Relationship Between Social Rank and Cortisol and Testosterone Concentrations in Male Cynomolgus Monkeys (Macaca fascicularis) , 2009, Journal of neuroendocrinology.
[6] M. Nader,et al. PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. , 2005, The American journal of psychiatry.
[7] E. London,et al. Dopamine D3 receptors as a therapeutic target for methamphetamine dependence , 2014, The American journal of drug and alcohol abuse.
[8] G. Sedvall,et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.
[9] J. Shearer,et al. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. , 2004, Addictive behaviors.
[10] J. Kebabian,et al. S-(+)-aporphines are not selective for human D3 dopamine receptors , 1994, Cellular and Molecular Neurobiology.
[11] D. Sibley,et al. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. , 2013, The international journal of neuropsychopharmacology.
[12] T. Barnes. Antipsychotic Drugs and their Side-Effects , 1993 .
[13] S. B. Caine,et al. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. , 2000, Experimental and clinical psychopharmacology.
[14] N. Mello,et al. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. , 2000 .
[15] W. Woolverton,et al. Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. , 1981, Drug and alcohol dependence.
[16] Michael A. Nader,et al. Individual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomolgus monkeys , 2011, Psychopharmacology.
[17] C. Heidbreder. Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[18] N. Volkow,et al. Therapeutic doses of buspirone block D3 receptors in the living primate brain. , 2014, The international journal of neuropsychopharmacology.
[19] D. Sibley,et al. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. , 2012, Biochemical pharmacology.
[20] K. Cunningham,et al. Dopamine D1 and D2 mediation of the discriminative stimulus properties ofd-amphetamine and cocaine , 2005, Psychopharmacology.
[21] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[22] M. Nader,et al. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys , 2006, Pharmacology Biochemistry and Behavior.
[23] N. Mello,et al. Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration , 2013, Neuropsychopharmacology.
[24] P. W. Czoty,et al. Effects of the 5-HT1A agonist (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on cocaine choice in cynomolgus monkeys , 2005, Behavioural pharmacology.
[25] J. Ginos,et al. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. , 1984, The Journal of pharmacology and experimental therapeutics.
[26] Rainer Enkelmann. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder , 2005, Psychopharmacology.
[27] M. Nader,et al. Nonhuman primate models of social behavior and cocaine abuse , 2012, Psychopharmacology.
[28] L. E. Thomson,et al. Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case study. , 1997, Journal of substance abuse treatment.
[29] T. Barnes,et al. THE SIDE-EFFECTS OF ANTIPSYCHOTIC DRUGS. I. CNS AND NEUROMUSCULAR EFFECTS , 1993 .
[30] J. Schmitz,et al. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. , 2009, Drug and alcohol dependence.
[31] M. Bardo,et al. Individual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused Drugs , 2013, Pharmacological Reviews.
[32] David R. Sibley,et al. Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes , 1999, Neuropsychopharmacology.
[33] R. Croop,et al. Pharmacokinetics of a Newly Identified Active Metabolite of Buspirone After Administration of Buspirone Over Its Therapeutic Dose Range , 2006, Journal of clinical pharmacology.
[34] A. Fink-Jensen,et al. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats , 2008, Psychopharmacology.
[35] S. Peroutka. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors , 1985, Biological Psychiatry.
[36] R. Taub,et al. 6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats , 2007, Drug Metabolism and Disposition.
[37] S. B. Caine,et al. Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists , 2002, The Journal of Neuroscience.
[38] L. Amato,et al. Dopamine agonists for the treatment of cocaine dependence. , 2011, The Cochrane database of systematic reviews.
[39] M. Nader,et al. Effects of Dopamine D2/D3 Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[40] R. De La Garza,et al. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. , 2012, Pharmacology & therapeutics.
[41] N. Mello,et al. Effects of Chronic Buspirone Treatment on Cocaine Self-Administration , 2013, Neuropsychopharmacology.
[42] M. Nader,et al. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm , 2014, Psychopharmacology.
[43] M. Mohammadi,et al. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. , 2012, Acta medica Iranica.
[44] S. Manuck,et al. Social Status, Environment, and Atherosclerosisin Cynomolgus Monkeys , 1982, Arteriosclerosis.
[45] M. Nader,et al. Effects of Two Novel D3-Selective Compounds, NGB 2904 [N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the Reinforcing and Discriminative Stimulus Effects of Cocaine in Rhesus M , 2007, Journal of Pharmacology and Experimental Therapeutics.
[46] Sylvain Houle,et al. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. , 2005, Journal of medicinal chemistry.
[47] K. Brady,et al. Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. , 2012, Contemporary clinical trials.
[48] Paul A Keller,et al. Control of hepatitis C: a medicinal chemistry perspective. , 2005, Journal of medicinal chemistry.
[49] M. Nader,et al. Assessment of the Relative Reinforcing Strength of Cocaine in Socially Housed Monkeys Using a Choice Procedure , 2005, Journal of Pharmacology and Experimental Therapeutics.
[50] M. Nader,et al. Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine , 2010, Psychopharmacology.
[51] Z. Xi,et al. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats , 2011, Journal of psychopharmacology.
[52] A. Newman,et al. Cocaine self-administration in dopamine D₃ receptor knockout mice. , 2012, Experimental and clinical psychopharmacology.
[53] L. Gold,et al. Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys , 2005, Psychopharmacology.
[54] M. Nader,et al. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration , 2002, Nature Neuroscience.
[55] M. Nader,et al. Social Dominance in Female Monkeys: Dopamine Receptor Function and Cocaine Reinforcement , 2012, Biological Psychiatry.
[56] A. Newman,et al. Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders , 2010, Annals of the New York Academy of Sciences.
[57] M. Banks,et al. Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration , 2012, Advances in pharmacological sciences.
[58] M. Nader,et al. Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. , 2005, Journal of medicinal chemistry.
[59] A. Stotts,et al. Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. , 2000, Journal of clinical psychopharmacology.
[60] J. Tallman,et al. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.
[61] Ji-Kyung Choi,et al. Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. , 2007, Journal of medicinal chemistry.
[62] S. Negus. Rapid Assessment of Choice between Cocaine and Food in Rhesus Monkeys: Effects of Environmental Manipulations and Treatment with d-Amphetamine and Flupenthixol , 2003, Neuropsychopharmacology.
[63] Sylvain Houle,et al. Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO , 2014, Neuropsychopharmacology.